Natural killer T (NKT) cells in autoimmune hepatitis

Current Opinion in Immunology

Volumn 25, Issue 6, 2013, Pages 697-703

  Mattner, Jochen ^a,b  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; CHEMOKINE; CYTOKINE; LIPID; LIPID ANTIGEN; UNCLASSIFIED DRUG;

ADAPTIVE IMMUNITY; ANTIGEN RECOGNITION; AUTOIMMUNE HEPATITIS; CYTOKINE RELEASE; HUMAN; IMMUNITY; IMMUNOLOGICAL TOLERANCE; IMMUNOMODULATION; INNATE IMMUNITY; LIVER CIRCULATION; NATURAL KILLER T CELL; NONHUMAN; PORTAL VEIN; REVIEW; T LYMPHOCYTE SUBPOPULATION; TISSUE DISTRIBUTION;

ANIMALS; FIBROSIS; HEPATITIS, AUTOIMMUNE; HUMANS; IMMUNE TOLERANCE; IMMUNITY, INNATE; LYMPHOCYTE ACTIVATION; NATURAL KILLER T-CELLS;

EID: 84889093427     PISSN: 09527915     EISSN: 18790372     Source Type: Journal    
DOI: 10.1016/j.coi.2013.09.008     Document Type: Review

References (85)

1. Hardtke-Wolenski M., Jaeckel E. Mouse models for experimental autoimmune hepatitis: limits and chances. Dig Dis 2010, 28:70-79.
2. Lukacs-Kornek V., Turley S.J. Self-antigen presentation by dendritic cells and lymphoid stroma and its implications for autoimmunity. Curr Opin Immunol 2011, 23:138-145.
3. Steward-Tharp S.M., Song Y.J., Siegel R.M., O'Shea J.J. New insights into T cell biology and T cell-directed therapy for autoimmunity, inflammation, and immunosuppression. Ann N Y Acad Sci 2010, 1183:123-148.
4. Crispe I.N. Hepatic T cells and liver tolerance. Nat Rev Immunol 2003, 3:51-62.
5. Nemeth E., Baird A.W., O'Farrelly C. Microanatomy of the liver immune system. Semin Immunopathol 2009, 31:333-343.
6. Klugewitz K., Adams D.H., Emoto M., Eulenburg K., Hamann A. The composition of intrahepatic lymphocytes: shaped by selective recruitment?. Trends Immunol 2004, 25:590-594.
7. Ibrahim J., Nguyen A.H., Rehman A., Ochi A., Jamal M., Graffeo C.S., Henning J.R., Zambirinis C.P., Fallon N.C., Barilla R., et al. Dendritic cell populations with different concentrations of lipid regulate tolerance and immunity in mouse and human liver. Gastroenterology 2012, 143:1061-1072.
8. Gordon S. Pattern recognition receptors: doubling up for the innate immune response. Cell 2002, 111:927-930.
9. Freigang S., Kain L., Teyton L. Transport and uptake of immunogenic lipids. Mol Immunol 2013, 55:179-181.
10. Berzins S.P., Smyth M.J., Baxter A.G. Presumed guilty: natural killer T cell defects and human disease. Nat Rev Immunol 2011, 11:131-142.
11. Brigl M., Brenner M.B. CD1: antigen presentation and T cell function. Annu Rev Immunol 2004, 22:817-890.
12. Facciotti F., Ramanjaneyulu G.S., Lepore M., Sansano S., Cavallari M., Kistowska M., Forss-Petter S., Ni G., Colone A., Singhal A., et al. Peroxisome-derived lipids are self antigens that stimulate invariant natural killer T cells in the thymus. Nat Immunol 2012, 13:474-480.
13. Chang Y.J., Kim H.Y., Albacker L.A., Lee H.H., Baumgarth N., Akira S., Savage P.B., Endo S., Yamamura T., Maaskant J., et al. Influenza infection in suckling mice expands an NKT cell subset that protects against airway hyperreactivity. J Clin Invest 2011, 121:57-69.
14. Fox L.M., Cox D.G., Lockridge J.L., Wang X., Chen X., Scharf L., Trott D.L., Ndonye R.M., Veerapen N., Besra G.S., et al. Recognition of lyso-phospholipids by human natural killer T lymphocytes. PLoS Biol 2009, 7:e1000228.
15. Tatituri R.V., Watts G.F., Bhowruth V., Barton N., Rothchild A., Hsu F.F., Almeida C.F., Cox L.R., Eggeling L., Cardell S., et al. Recognition of microbial and mammalian phospholipid antigens by NKT cells with diverse TCRs. Proc Natl Acad Sci U S A 2013, 110:1827-1832.
16. Jahng A., Maricic I., Aguilera C., Cardell S., Halder R.C., Kumar V. Prevention of autoimmunity by targeting a distinct, noninvariant CD1d-reactive T cell population reactive to sulfatide. J Exp Med 2004, 199:947-957.
17. Blomqvist M., Rhost S., Teneberg S., Löfbom L., Osterbye T., Brigl M., Månsson J.E., Cardell S.L. Multiple tissue-specific isoforms of sulfatide activate CD1d-restricted type II NKT cells. Eur J Immunol 2009, 39:1726-1735.
18. Bendelac A., Savage P.B., Teyton L. The biology of NKT cells. Annu Rev Immunol 2007, 25:297-336.
19. Emoto M., Kaufmann S.H. Liver NKT cells: an account of heterogeneity. Trends Immunol 2003, 24:364-369.
20. Subleski J.J., Hall V.L., Wolfe T.B., Scarzello A.J., Weiss J.M., Chan T., Hodge D.L., Back T.C., Ortaldo J.R., Wiltrout R.H. TCR-dependent and -independent activation underlie liver-specific regulation of NKT cells. J Immunol 2011, 186:838-847.
21. Velazquez P., Cameron T.O., Kinjo Y., Nagarajan N., Kronenberg M., Dustin M.L. Cutting edge: activation by innate cytokines or microbial antigens can cause arrest of natural killer T cell patrolling of liver sinusoids. J Immunol 2008, 180:2024-2028.
22. Mattner J., Debord K.L., Ismail N., Goff R.D., Cantu C., Zhou D., Saint-Mezard P., Wang V., Gao Y., Yin N., Hoebe K., et al. Exogenous and endogenous glycolipid antigens activate NKT cells during microbial infections. Nature 2005, 434:525-529.
23. Winau F., Hegasy G., Weiskirchen R., Weber S., Cassan C., Sieling P.A., Modlin R.L., Liblau R.S., Gressner A.M., Kaufmann S.H. Ito cells are liver-resident antigen-presenting cells for activating T cell responses. Immunity 2007, 26:117-129.
24. Schmieg J., Yang G., Franck R.W., Van Rooijen N., Tsuji M. Glycolipid presentation to natural killer T cells differs in an organ-dependent fashion. Proc Natl Acad Sci U S A 2005, 102:1127-1132.
25. Geissmann F., Cameron T.O., Sidobre S., Manlongat N., Kronenberg M., Briskin M.J., Dustin M.L., Littman D.R. Intravascular immune surveillance by CXCR6+ NKT cells patrolling liver sinusoids. PLoS Biol 2005, 3:e113.
26. De Santo C., Salio M., Masri S.H., Lee L.Y., Dong T., Speak A.O., Porubsky S., Booth S., Veerapen N., Besra G.S., et al. Invariant NKT cells reduce the immunosuppressive activity of influenza A virus-induced myeloid-derived suppressor cells in mice and humans. J Clin Invest 2008, 118:4036-4048.
27. Zeissig S., Murata K., Sweet L., Publicover J., Hu Z., Kaser A., Bosse E., Iqbal J., Hussain M.M., Balschun K., et al. Hepatitis B virus-induced lipid alterations contribute to natural killer T cell-dependent protective immunity. Nat Med 2012, 18:1060-1068.
28. Wong C.H., Jenne C.N., Lee W.Y., Léger C., Kubes P. Functional innervation of hepatic iNKT cells is immunosuppressive following stroke. Science 2011, 334:101-105.
29. Emoto M., Mittrücker H.W., Schmits R., Mak T.W., Kaufmann S.H. Critical role of leukocyte function-associated antigen-1 in liver accumulation of CD4+NKT cells. J Immunol 1999, 162:5094-5098.
30. Thomas S.Y., Scanlon S.T., Griewank K.G., Constantinides M.G., Savage A.K., Barr K.A., Meng F., Luster A.D., Bendelac A. PLZF induces an intravascular surveillance program mediated by long-lived LFA-1-ICAM-1 interactions. J Exp Med 2011, 208:1179-1188.
31. Invernizzi P., Lleo A., Podda M. Interpreting serological tests in diagnosing autoimmune liver diseases. Semin Liver Dis 2007, 27:161-172.
32. Kaplan M.M., Gershwin M.E. Primary biliary cirrhosis. N Engl J Med 2005, 353:1261-1273.
33. Bogdanos D.P., Invernizzi P., Mackay I.R., Vergani D. Autoimmune liver serology: current diagnostic and clinical challenges. World J Gastroenterol 2008, 14:3374-3387.
34. Oo Y.H., Hubscher S.G., Adams D.H. Autoimmune hepatitis: new paradigms in the pathogenesis, diagnosis, and management. Hepatol Int 2010, 4:475-493.
35. Marshak-Rothstein A., Rifkin I.R. Immunologically active autoantigens: the role of toll-like receptors in the development of chronic inflammatory disease. Annu Rev Immunol 2007, 25:419-441.
36. Holdener M., Hintermann E., Bayer M., Rhode A., Rodrigo E., Hintereder G., Johnson E.F., Gonzalez F.J., Pfeilschifter J., Manns M.P., et al. Breaking tolerance to the natural human liver autoantigen cytochrome P450 2D6 by virus infection. J Exp Med 2008, 205:1409-1422.
37. Lapierre P., Beland K., Alvarez F. Autoimmune hepatitis experimental model based on adenoviral infections. Hepatology 2013, [Epub ahead of print].
38. Aoki N., Kido M., Iwamoto S., Nishiura H., Maruoka R., Tanaka J., Watanabe T., Tanaka Y., Okazaki T., Chiba T., Watanabe N. Dysregulated generation of follicular helper T cells in the spleen triggers fatal autoimmune hepatitis in mice. Gastroenterology 2011, 140:1322-1333.
39. Smyk D.S., Rigopoulou E.I., Bogdanos D.P. Potential roles for infectious agents in the pathophysiology of primary biliary cirrhosis: what's new?. Curr Infect Dis Rep 2013, 15:14-24.
40. Olsson R., Björnsson E., Bäckman L., Friman S., Höckerstedt K., Kaijser B., Olausson M. Bile duct bacterial isolates in primary sclerosing cholangitis: a study of explanted livers. J Hepatol 1998, 28:426-432.
41. Mattner J., Savage P.B., Leung P., Oertelt S.S., Wang V., Trivedi O., Scanlon S.T., Pendem K., Teyton L., Hart J., et al. Liver autoimmunity triggered by microbial activation of natural killer T cells. Cell Host Microbe 2008, 3:304-315.
42. Selmi C., Balkwill D.L., Invernizzi P., Ansari A.A., Coppel R.L., Podda M., Leung P.S., Kenny T.P., Van De Water J., Nantz M.H., et al. Patients with primary biliary cirrhosis react against a ubiquitous xenobiotic-metabolizing bacterium. Hepatology 2003, 38:1250-1257.
43. Padgett K.A., Selmi C., Kenny T.P., Leung P.S., Balkwill D.L., Ansari A.A., Coppel R.L., Gershwin M.E., et al. Phylogenetic and immunological definition of four lipoylated proteins from Novosphingobium aromaticivorans, implications for primary biliary cirrhosis. J Autoimmun 2005, 24:209-219.
44. Halder R.C., Aguilera C., Maricic I., Kumar V. Type II NKT cell-mediated anergy induction in type I NKT cells prevents inflammatory liver disease. J Clin Invest 2007, 117:2302-2312.
45. Arrenberg P., Halder R., Kumar V. Cross-regulation between distinct natural killer T cell subsets influences immune response to self and foreign antigens. J Cell Physiol 2009, 218:246-250.
46. Kita H., Naidenko O.V., Kronenberg M., Ansari A.A., Rogers P., He X.S., Koning F., Mikayama T., Van De Water J., Coppel R.L., et al. Quantitation and phenotypic analysis of natural killer T cells in primary biliary cirrhosis using a human CD1d tetramer. Gastroenterology 2002, 123:1031-1043.
47. Chuang Y.H., Lian Z.X., Yang G.X., Shu S.A., Moritoki Y., Ridgway W.M., Ansari A.A., Kronenberg M., Flavell R.A., Gao B., Gershwin M.E. Natural killer T cells exacerbate liver injury in a transforming growth factor beta receptor II dominant-negative mouse model of primary biliary cirrhosis. Hepatology 2008, 47:571-580.
48. Takeda K., Hayakawa Y., Van Kaer L., Matsuda H., Yagita H., Okumura K. Critical contribution of liver natural killer T cells to a murine model of hepatitis. Proc Natl Acad Sci U S A 2000, 97:5498-5503.
49. Biburger M., Tiegs G. Alpha-galactosylceramide-induced liver injury in mice is mediated by TNF-alpha but independent of Kupffer cells. J Immunol 2005, 175:1540-1550.
50. Chen J., Duan L., Xiong A., Zhang H., Zheng F., Tan Z., Gong F., Fang M. Blockade of IL-33 ameliorates Con A-induced hepatic injury by reducing NKT cell activation and IFN-gamma production in mice. J Mol Med (Berl) 2012, 90:1505-1515.
51. Kaneko Y., Harada M., Kawano T., Yamashita M., Shibata Y., Gejyo F., Nakayama T., Taniguchi M. Augmentation of Valpha14 NKT cell-mediated cytotoxicity by interleukin 4 in an autocrine mechanism resulting in the development of concanavalin A-induced hepatitis. J Exp Med 2000, 191:105-114.
52. Iwamoto S., Kido M., Aoki N., Nishiura H., Maruoka R., Ikeda A., Okazaki T., Chiba T., Watanabe N. TNF-alpha is essential in the induction of fatal autoimmune hepatitis in mice through upregulation of hepatic CCL20 expression. Clin Immunol 2013, 146:15-25.
53. Kato J., Okamoto T., Motoyama H., Uchiyama R., Kirchhofer D., Van Rooijen N., Enomoto H., Nishiguchi S., Kawada N., Fujimoto J., Tsutsui H. Interferon-gamma-mediated tissue factor expression contributes to T-cell-mediated hepatitis through induction of hypercoagulation in mice. Hepatology 2013, 57:362-372.
54. Wang H., Feng D., Park O., Yin S., Gao B. Invariant NKT cell activation induces neutrophil accumulation and hepatitis: oppositely regulated by IL-4 and IFN-gamma. Hepatology 2013, [Epub ahead of print].
55. Longhi M.S., Liberal R., Holder B., Robson S.C., Ma Y., Mieli-Vergani G., Vergani D. Inhibition of interleukin-17 promotes differentiation of CD25(-) cells into stable T regulatory cells in patients with autoimmune hepatitis. Gastroenterology 2012, 142:1526-1535. e6.
56. Yan S., Wang L., Liu N., Wang Y., Chu Y. Critical role of interleukin-17/interleukin-17 receptor axis in mediating Con A-induced hepatitis. Immunol Cell Biol 2012, 90:421-428.
57. Li B., Sun R., Wei H., Gao B., Tian Z. Interleukin-15 prevents concanavalin A-induced liver injury in mice via NKT cell-dependent mechanism. Hepatology 2006, 43:1211-1219.
58. Sprengers D., Sillé F.C., Derkow K., Besra G.S., Janssen H.L., Schott E., Boes M. Critical role for CD1d-restricted invariant NKT cells in stimulating intrahepatic CD8 T-cell responses to liver antigen. Gastroenterology 2008, 134:2132-2143.
59. Lehuen A., Diana J., Zaccone P., Cooke A. Immune cell crosstalk in type 1 diabetes. Nat Rev Immunol 2010, 10:501-513.
60. Ishikawa S., Ikejima K., Yamagata H., Aoyama T., Kon K., Arai K., Takeda K., Watanabe S. CD1d-restricted natural killer T cells contribute to hepatic inflammation and fibrogenesis in mice. J Hepatol 2011, 54:1195-1204.
61. Park O., Jeong W.I., Wang L., Wang H., Lian Z.X., Gershwin M.E., Gao B. Diverse roles of invariant natural killer T cells in liver injury and fibrosis induced by carbon tetrachloride. Hepatology 2009, 49:1683-1694.
62. Wehr A., Baeck C., Heymann F., Niemietz P.M., Hammerich L., Martin C., Zimmermann H.W., Pack O., Gassler N., Hittatiya K., et al. Chemokine receptor CXCR6-dependent hepatic NK T cell accumulation promotes inflammation and liver fibrosis. J Immunol 2013, 190:5226-5536.
63. Jin Z., Sun R., Wei H., Gao X., Chen Y., Tian Z. Accelerated liver fibrosis in hepatitis B virus transgenic mice: involvement of natural killer T cells. Hepatology 2011, 53:219-229.
64. Wu S.J., Yang Y.H., Tsuneyama K., Leung P.S., Illarionov P., Gershwin M.E., Chuang Y.H. Innate immunity and primary biliary cirrhosis: activated invariant natural killer T cells exacerbate murine autoimmune cholangitis and fibrosis. Hepatology 2011, 53:915-925.
65. Syn W.K., Oo Y.H., Pereira T.A., Karaca G.F., Jung Y., Omenetti A., Witek R.P., Choi S.S., Guy C.D., Fearing C.M., et al. Accumulation of natural killer T cells in progressive nonalcoholic fatty liver disease. Hepatology 2010, 51:1998-2007.
66. Karlmark K.R., Wasmuth H.E., Trautwein C., Tacke F. Chemokine-directed immune cell infiltration in acute and chronic liver disease. Expert Rev Gastroenterol Hepatol 2008, 2:233-242.
67. Zimmermann H.W., Tacke F. Modification of chemokine pathways and immune cell infiltration as a novel therapeutic approach in liver inflammation and fibrosis. Inflamm Allergy Drug Targets 2011, 10:509-536.
68. Nakashima H., Kinoshita M., Nakashima M., Habu Y., Shono S., Uchida T., Shinomiya N., Seki S. Superoxide produced by Kupffer cells is an essential effector in concanavalin A-induced hepatitis in mice. Hepatology 2008, 48:1979-1988.
69. Zhu R., Diem S., Araujo L.M., Aumeunier A., Denizeau J., Philadelphe E., Damotte D., Samson M., Gourdy P., Dy M., et al. The Pro-Th1 cytokine IL-12 enhances IL-4 production by invariant NKT cells: relevance for T cell-mediated hepatitis. J Immunol 2007, 178:5435-5442.
70. Erhardt A., Biburger M., Papadopoulos T., Tiegs G. IL-10, regulatory T cells, and Kupffer cells mediate tolerance in concanavalin A-induced liver injury in mice. Hepatology 2007, 45:475-485.
71. Milovanovic M., Volarevic V., Radosavljevic G., Jovanovic I., Pejnovic N., Arsenijevic N., Lukic M.L. IL-33/ST2 axis in inflammation and immunopathology. Immunol Res 2012, 52:89-99.
72. Deng Z.B., Zhuang X., Ju S., Xiang X., Mu J., Liu Y., Jiang H., Zhang L., Mobley J., McClain C., et al. Exosome-like nanoparticles from intestinal mucosal cells carry prostaglandin E2 and suppress activation of liver NKT cells. J Immunol 2013, 190:3579-3589.
73. Lee K.A., Song Y.C., Kim G.Y., Choi G., Lee Y.S., Lee J.M., Kang C.Y. Retinoic acid alleviates Con A-induced hepatitis and differentially regulates effector production in NKT cells. Eur J Immunol 2012, 42:1685-1694.
74. Kawamura T., Takeda K., Kaneda H., Matsumoto H., Hayakawa Y., Raulet D.H., Ikarashi Y., Kronenberg M., Yagita H., Kinoshita K., et al. NKG2A inhibits invariant NKT cell activation in hepatic injury. J Immunol 2009, 182:250-258.
75. Vilarinho S., Ogasawara K., Nishimura S., Lanier L.L., Baron J.L. Blockade of NKG2D on NKT cells prevents hepatitis and the acute immune response to hepatitis B virus. Proc Natl Acad Sci U S A 2007, 104:18187-18192.
76. Joshi S.K., Lang M.L. Fine tuning a well-oiled machine: influence of NK1.1 and NKG2D on NKT cell development and function. Int Immunopharmacol 2013, [Epub ahead of print].
77. Okuyama H., Yoshida T., Son A., Oka S., Wang D., Nakayama R., Masutani H., Nakamura H., Nabeshima Y., Yodoi J. Thioredoxin binding protein 2 modulates natural killer T cell-dependent innate immunity in the liver: possible link to lipid metabolism. Antioxid Redox Signal 2009, 11:2585-2593.
78. Deng Z.B., Zhuang X., Ju S., Xiang X., Mu J., Wang Q., Jiang H., Zhang L., Kronenberg M., Yan J., Miller D., Zhang H.G. Intestinal mucus-derived nanoparticle-mediated activation of Wnt/beta-catenin signaling plays a role in induction of liver natural killer T cell anergy in mice. Hepatology 2013, 57:1250-1261.
79. Wang X.F., Lei Y., Chen M., Chen C.B., Ren H., Shi T.D. PD-1/PDL1 and CD28/CD80 pathways modulate natural killer T cell function to inhibit hepatitis B virus replication. J Viral Hepat 2013, 20(Suppl. 1):27-39.
80. Bai L., Constantinides M.G., Thomas S.Y., Reboulet R., Meng F., Koentgen F., Teyton L., Savage P.B., Bendelac A. Distinct APCs explain the cytokine bias of alpha-galactosylceramide variants in vivo. J Immunol 2012, 188:3053-3061.
81. Fusakio M.E., Mohammed J.P., Laumonnier Y., Hoebe K., Köhl J., Mattner J. C5a regulates NKT and NK cell functions in sepsis. J Immunol 2011, 187:5805-5812.
82. Mohammed J.P., Fusakio M.E., Rainbow D.B., Moule C., Fraser H.I., Clark J., Todd J.A., Peterson L.B., Savage P.B., Wills-Karp M., et al. Identification of Cd101 as a susceptibility gene for Novosphingobium aromaticivorans-induced liver autoimmunity. J Immunol 2011, 187:337-349.
83. Wei B., Wingender G., Fujiwara D., Chen D.Y., McPherson M., Brewer S., Borneman J., Kronenberg M., Braun J. Commensal microbiota and CD8+ T cells shape the formation of invariant NKT cells. J Immunol 2010, 184:1218-1226.
84. Wingender G., Stepniak D., Krebs P., Lin L., McBride S., Wei B., Braun J., Mazmanian S.K., Kronenberg M. Intestinal microbes affect phenotypes and functions of invariant natural killer T cells in mice. Gastroenterology 2012, 143:418-428.
85. Olszak T., An D., Zeissig S., Vera M.P., Richter J., Franke A., Glickman J.N., Siebert R., Baron R.M., Kasper D.L., Blumberg R.S. Microbial exposure during early life has persistent effects on natural killer T cell function. Science 2012, 336:489-493.